Concurrent And Longitudinal Association Between Glycemic Control And Self Reported Medication Adherence Among Type 2 Diabetes Patients At A Tertiary Care Hospital In Malaysia

Current Diabetes Reviews
Mubashra ButtMohd Makmor Bakry

Abstract

This study evaluated the association between self-reported adherence with concurrent and subsequent glycemic control amongst type 2 diabetes patients at a tertiary care hospital in Malaysia. Demographic and clinical variables were assessed at baseline, after three and six months in 73 type 2 diabetes patients. Regression analysis, using SPSS, evaluated the concurrent and longitudinal association of medication adherence and glycemic control. Potential confounders of variables were identified using bi-variate correlation analyses. Concurrent Medication adherence and HbA1c association were significant after adjusting for ethnicity (P = 0.005). For longitudinal observation at 3 months, the association was significant after adjusting for ethnicity (P = 0.016); however, it became non-significant when baseline glycemic control was included in the model (P = 0.28). Easy to administer MALMAS significantly predicted concurrent glycemic control independent of potential confounders. This association persisted in longitudinal observation after 3 months when adjusted for confounders and became non-significant after adjusting for baseline glycemic control.

References

Apr 28, 2004·Diabetes Care·Joyce A Cramer
Jul 9, 2004·The Annals of Pharmacotherapy·Kimberley KrapekTeresa J Lubowski
Mar 31, 2005·The Diabetes Educator·Mary K RheeLawrence S Phillips
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Aug 19, 2005·The New England Journal of Medicine·Amal N TrivediJohn Z Ayanian
Sep 21, 2007·Journal of General Internal Medicine·Walid F GelladDana Gelb Safran
Nov 2, 2011·Oman Medical Journal·Beena Jimmy, Jimmy Jose
Oct 19, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·J E Aikens, J D Piette
Dec 21, 2013·Journal of Diabetes and Metabolic Disorders·Aliasghar A KiadaliriMaryam Mirmalek-Sani
Apr 23, 2015·Current Diabetes Reviews·Priscilla W PowellRandi Streisand
Feb 24, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mubashra ButtNorlaila Mustafa
Aug 16, 2016·Patient Preference and Adherence·William H Polonsky, Robert R Henry
Mar 1, 2015·Expert Review of Endocrinology & Metabolism·Jayne Smith-PalmerJay P Bae

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.